代谢组学在心脏死亡器官捐献供肝评估中的应用

张毅; 杨卿; 吕海金; 傅斌生; 刘炜

doi:10.3969/j.issn.1674-7445.2017.06.012

代谢组学在心脏死亡器官捐献供肝评估中的应用

doi: 10.3969/j.issn.1674-7445.2017.06.012

510630 广州，中山大学附属第三医院肝脏外科暨肝移植中心（张毅、杨卿、傅斌生）；外科重症医学科（吕海金）；广东省肝脏疾病研究重点实验室（刘炜）

基金项目:

广东省科技计划项目 2014B020228003

广东省科技计划项目 2014B030301041

广东省科技计划项目 2015B020226004

广东省自然科学基金项目 2014A030313131

广东省自然科学基金项目 2016A030313195

广东省自然科学基金项目 2015A030312013

广州市科技计划项目 201400000001-3

广州市科技计划项目 201508020262

张毅、杨卿为共同第一作者

详细信息

通讯作者:
傅斌生, Email: andyfu79@163.com

刘炜, Email: lwei6@mail.sysu.edu.cn

中图分类号: R617, R333.6
计量
- 文章访问数: 120
- HTML全文浏览量: 52
- PDF下载量: 14
- 被引次数: 0
出版历程
- 收稿日期: 2017-08-06
- 网络出版日期: 2021-01-19
- 刊出日期: 2017-11-15

摘要

摘要: 肝移植技术在国内日益普及，但仍然面临着供肝严重短缺的困境。心脏死亡器官捐献（DCD）是我国目前供肝的主要来源，其供肝质量的评估方法仍亟待完善。近年新兴的代谢组学研究方法，为移植器官质量的评估提供了一个崭新的角度。本文主要综述了目前国内器官捐献的现状，介绍了代谢组学研究的产生和进展及其在肝移植尤其是供肝质量评估中的应用前景。
- 心脏死亡器官捐献 /
- 供体评估 /
- 代谢组学 /
- 肝移植 /
- 乙型病毒性肝炎 /
- 气相色谱-质谱联用技术 /
- 液相色谱-质谱联用技术 /
- 早期移植物功能障碍 /
- 原发性无功能
注释:

HTML全文

参考文献(30)

[1]	中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南(2015更新版)[J].中华肝脏病杂志, 2015, 23(12): 888-905. DOI: 10.3760/cma.j.issn.1007-3418.2015.12.002. Branch of Hepatology of Chinese Medical Association, Branch of Infectious Diseases of Chinese Medical Association. The guideline of prevention and treatment for chronic hepatitis B:a 2015 update[J]. Chin J Hepatol, 2015, 23(12): 888-905. DOI: 10.3760/cma.j.issn.1007-3418.2015.12.002.
[2]	Starzl TE. The long reach of liver transplantation[J]. Nat Med, 2012, 18(10): 1489-1492. DOI: 10.1038/nm.2927.
[3]	郑树森, 俞军, 张武, 等.肝移植在中国的发展现状[J].临床肝胆病杂志, 2014, 30(1): 2-4. DOI: 10.3969/j.issn.1001-5256.2014.01.001. Zheng SS, Yu J, Zhang W, et al. Current development of liver transplantation in China[J]. J Clin Hepatol, 2014, 30(1): 2-4. DOI: 10.3969/j.issn.1001-5256.2014.01.001.
[4]	黄洁夫.推动我国器官移植事业健康发展的关键性举措——心死亡器官捐献试点工作原则性思考[J].中华器官移植杂志, 2011, 32(1): 1-4. DOI: 10.3760/cma.j.issn.0254-1785.2011.01.001. Huang JF. The key measures promoting the development of organ transplantation projects in China: principal thinking about experimental units for heart death organ donation[J]. Chin J Organ Transplant, 2011, 32(1): 1-4. DOI: 10.3760/cma.j.issn.0254-1785.2011.01.001.
[5]	Casavilla A, Ramirez C, Shapiro R, et al. Experience with liver and kidney allografts from non-heart-beating donors[J]. Transplantation, 1995, 59(2): 197-203. doi: 10.1097/00007890-199501000-00008
[6]	Mallik M, Callaghan CJ, Hope M, et al. Comparison of liver transplantation outcomes from adult split liver and circulatory death donors[J]. Br J Surg, 2012, 99(6): 839-847. DOI: 10.1002/bjs.8755.
[7]	Kootstra G, Daemen JH, Oomen AP. Categories of non-heart-beating donors[J]. Transplant Proc, 1995, 27(5): 2893-2894. https://academic.oup.com/bjaed
[8]	Ridley S, Bonner S, Bray K, et al. UK guidance for non-heart-beating donation[J]. Br J Anaesth, 2005, 95(5): 592-595. DOI: 10.1093/bja/aei235.
[9]	唐晖, 傅斌生, 陈规划.心脏死亡器官捐献肝移植的供体功能维护[J].器官移植, 2016, 7(1): 21-25. DOI: 10.3969/j.issn.1674-7445. 2016. 01.004. Tang H, Fu BS, Chen GH. Donor function maintenance of liver transplantation from donation after cardiac death[J]. Organ Transplant, 2016, 7(1):21-25. DOI: 10.3969/j.issn.1674-7445. 2016. 01.004.
[10]	Mathur AK, Heimbach J, Steffick DE, et al. Donation after cardiac death liver transplantation: predictors of outcome[J]. Am J Transplant, 2010, 10(11): 2512-2519. DOI: 10.1111/j.1600-6143.2010.03293.x.
[11]	Jay C, Ladner D, Wang E, et al. A comprehensive risk assessment of mortality following donation after cardiac death liver transplant -an analysis of the national registry[J]. J Hepatol, 2011, 55(4): 808-813. DOI: 10.1016/j.jhep.2011.01.040.
[12]	Dubbeld J, Hoekstra H, Farid W, et al. Similar liver transplantation survival with selected cardiac death donors and brain death donors[J]. Br J Surg, 2010, 97(5): 744-753. DOI: 10.1002/bjs.7043.
[13]	傅斌生, 易述红, 唐晖, 等.公民逝世后器官捐献供肝质量评估和维护的体会[J].器官移植, 2016, 7(3): 215-218. DOI: 10.3969/j.issn.1674-7445.2016.03.011. Fu BS, Yi SH, Tang H, et al. Experience of quality evaluation and function maintenance of donor liver from organ donation after citizen's death[J]. Organ Transplant, 2016, 7(3): 215-218. DOI: 10.3969/j.issn.1674-7445.2016.03.011.
[14]	中华医学会器官移植学分会, 中华医学会外科学分会移植学组, 中国医师协会器官移植医师分会, 等. 中国心脏死亡捐献器官评估与应用专家共识[J/CD]. 中华移植杂志(电子版), 2014, 8(3): 117-122. DOI: 10.3877/cma.j.issn.1647-3903.2014.03.001. Organ Transplantation Branch of Chinese Medical Association, Transplantation Group of Surgery Branch of Chinese Medical Association, Organ Transplant Physicians Branch of Chinese Medical Doctor Association, et al. Expert consensus on evaluation and application of organ donated after cardiac death in China[J/CD]. Chin J Transplant(Electr Edit), 2014, 8(3): 117-122. DOI: 10.3877/cma.j.issn.1647-3903.2014.03.001.
[15]	Garofolo F, Savoie N, Bergeron A, et al. Importance of metabolite testing in regulated bioanalysis[J]. Bioanalysis, 2010, 2(7): 1171-1174. DOI: 10.4155/bio.10.15.
[16]	Ott KH, Araníbar N, Singh B, et al. Metabonomics classifies pathways affected by bioactive compounds. artificial neural network classification of NMR spectra of plant extracts[J]. Phytochemistry, 2003, 62(6): 971-985. doi: 10.1016/S0031-9422(02)00717-3
[17]	Nicholson JK, Connelly J, Lindon JC, et al. Metabonomics: a platform for studying drug toxicity and gene function[J]. Nat Rev Drug Discov, 2002, 1(2): 153-161. DOI: 10.1038/nrd728.
[18]	Fiehn O. Combining genomics, metabolome analysis, and biochemical modelling to understand metabolic networks[J]. Comp Funct Genomics, 2001, 2(3): 155-168. DOI: 10.1002/cfg.82.
[19]	Gates SC, Sweeley CC. Quantitative metabolic profiling based on gas chromatography[J]. Clin Chem, 1978, 24(10): 1663-1673. http://d.wanfangdata.com.cn/OAPaper/oai_doaj-articles_295cd66fad561e8c0964205ad4f3c7ea
[20]	Deyl Z, Hyanek J, Horakova M. Profiling of amino acids in body fluids and tissues by means of liquid chromatography[J]. J Chromatogr, 1986, 379: 177-250. doi: 10.1016/S0378-4347(00)80685-4
[21]	Oliver SG. From gene to screen with yeast[J]. Curr Opin Genet Dev, 1997, 7(3): 405-409. doi: 10.1016/S0959-437X(97)80156-6
[22]	Nicholson JK, Lindon JC, Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data[J]. Xenobiotica, 1999, 29(11): 1181-1189. DOI: 10.1080/004982599238047.
[23]	Brindle JT, Antti H, Holmes E, et al. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics[J]. Nat Med, 2002, 8(12): 1439-1444. DOI: 10.1038/nm802.
[24]	Yang J, Xu G, Zheng Y, et al. Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2004, 813(1/2): 59-65. DOI: 10.1016/j.jchromb.2004.09.032.
[25]	Cortes M, Pareja E, García-Cañaveras JC, et al. Metabolomics discloses donor liver biomarkers associated with early allograft dysfunction[J]. J Hepatol, 2014, 61(3): 564-574. DOI: 10.1016/j.jhep.2014.04.023.
[26]	Saude EJ, Lacy P, Musat-Marcu S, et al. NMR analysis of neutrophil activation in sputum samples from patients with cystic fibrosis[J]. Magn Reson Med, 2004, 52(4): 807-814. DOI: 10.1002/mrm.20242.
[27]	Bruinsma BG, Sridharan GV, Weeder PD, et al. Metabolic profiling during ex vivo machine perfusion of the human liver[J]. Sci Rep, 2016, 6: 22415. DOI: 10.1038/srep22415.
[28]	Ceglarek U, Kresse K, Becker S, et al. Circulating sterols as predictors of early allograft dysfunction and clinical outcome in patients undergoing liver transplantation[J]. Metabolomics, 2016, 12(12): 182. DOI: 10.1007/s11306-016-1129-z.
[29]	Hrydziuszko O, Perera MT, Laing R, et al. Mass spectrometry based metabolomics comparison of liver grafts from donors after circulatory death (DCD) and donors after brain death(DBD) used in humanorthotopic liver transplantation[J]. PLoS One, 2016, 11(11): e0165884. DOI: 10.1371/journal.pone.0165884.
[30]	Yang QJ, Kluger M, Goryński K, et al. Comparing early liver graft function from heart beating and living-donors: a pilot study aiming to identify new biomarkers of liver injury[J]. Biopharm Drug Dispos, 2017, 38(5): 326-339. DOI: 10.1002/bdd.2066.